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1. Introduction 
Very good survival rates have been achieved in patients with end stage liver disease after 
orthotopic liver transplantation (OLT), but in the MELD (model of end stage liver disease) 
era, the gap between patients in the need of OLT and available grafts has widened, leading 
to acceptance of marginal organs. This is one of the most important reasons for a 
complicated postoperative course, having  a greater risk of graft or multiorgan dysfunction 
and systemic infection. The result of these factors is the increase of posttransplant morbidity 
and mortality [1].  
Sepsis is the most common cause of mortality, especially in patients undergoing an 
immunsuppressive therapy and in these after a major surgical treatment. Despite the 
development and administration of new antimicrobial therapeutic modalities, the mortality 
rate of sepsis remains high over the last decades because of the high co morbidity and often 
because of delayed establishment of the diagnosis and treatment [1-4].  
1.1. Sepsis and systemic inflammatory response syndrom 
Sepsis and systemic inflammation response syndrome (SIRS) induce rapid and profound 
changes in endothelial function. The endothelial cells from their side trigger the immune 
response and activate the coagulation system. Endothelial cells cover the surface of blood 
vessels and are directly in tight contact with solid organs. This is the reason, why 
endothelial activation and damage leads to organ dysfunction. The endothelium plays also 
an important role in local and systemic immune responses; it is considered both as source of 
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and as target for inflammation [5]. In cases of local activation of the endothelium there is an 
isolation of infectious procedures. On the other side and in cases of systemic activation the 
results are capillary leakage, hypotension and microvascular thrombosis. These aspects 
result in tissue hypoxia, and organ dysfunction [6– 10]. 
In cases of inflammation, systemic infection and sepsis there is a constant exposure of these 
endothelial cells to the circulating endotoxins and proinflammatory cytokines such as 
interleucin 6 (IL-6), interleucin 1 (IL-1), interleucin 8 (IL-8), tumor necrosis factor α (TNF α) 
and this leads to an activation of the endothelium and expression of endothelial leucocyte 
adhesion molecule (ELAM-1), intercellular adhesion molecule (ICAM-1) and vascular cell 
adhesion molecule (VCAM-1, 8). In cases of severe systemic inflammation and sepsis there 
is a significant level increase of these adhesion molecules and they could have a very good 
prognostic and diagnostic power, on the other side with a low specificity as far as the origin 
of the inflammation is concerned (infectious, non-infectious).  
1.2. Markers for sepsis 
Markers of sepsis and endothelial activation could potentially play a role in prediction and 
early diagnosis of onset and severity of the systemic inflammation and through 
differentiation between infectious and non-infectious causes of the SIRS. 
The endothelial adhesion molecules (ELAM-1, ICAM-1 and VCAM1) are not sufficiently 
investigated and due to lack of specificity do not play a role in the clinical area.  
A milestone in the sepsis era was the introduction of IL-6. IL-6, produced by various cell 
types, such as macrophages, monocytes and endothelial cells, can be stimulated be 
through bacteria, viruses, polysaccharides, TNF-α, interferons (especially interferon γ) 
and platelet derivated growth factor (PDGF). Through its very high sensitivity there was a 
reasonable euphoria, as many thought that the "ideal sepsis marker" was found. However 
and after introduction of the study of Habarth et al [11,12], who examined combined the 
diagnostic relevance of IL-6 and PCT in terms of sepsis,  it was shown that the diagnostic 
accuracy of IL-6 is impaired through inflammation procedures independent of infection. 
On the other hand PCT seemed to have a better correlation to septic episodes and 
infection. 
1.3. Sepsis and SIRS in hepatic dysfunction and after OLT 
Liver transplant recipients often manifest a systemic inflammatory response syndrome 
(SIRS), because of various surgical and non surgical procedures, such as induction of the 
immunsuppressive therapy and reperfusion during transplantation, independently of the 
presence of an infectious focus. The clinical signs of infection and routine laboratory tests 
are not specific and are sometimes misleading. The lack of specific early markers of infection 
might be responsible in part for delaying of a targeted antimicrobial treatment in this patient 
population. Moreover, the uncontrolled use of wide spectrum antimicrobial agents as 
"prophylactic therapy" without use of terms of the pre-emptive therapy is leading to 
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bacterial translocation and the presence of multiresistant microorganisms, which further 
impairs the patients' outcome [13-20]. 
Patients with impaired hepatic function are susceptible to an infectious episode because of 
immunologic deficits in the period before OLT. Impaired immunologic mechanisms 
resulting from the hepatic function deficit such as decreased hepatic production of 
complement, impaired Kupffer cell function, impairment of neutrophil chemotaxis, and of 
inflammatory cytokines [15-20]. Due to the immunological deficit there is also a decreased 
activity of immunoglobulins as answer to the circulation of gram-negative pathogens [20]. 
In the presence of structural and functional impairment of the liver, there is a damage of 
filtering by impaired macrophage mobilization and diminished killing of bacteria [20]. 
These described deficits lead to an increased risk for systemic infection in the early 
posttransplant setting and this fact is the most frequent and dangerous complication 
occurring after OLT. Mora et al, Singh et al and Lee et al reported in their studies the 
relevance of the early and late bacteriemia in liver transplant recipients, the higher mortality 
rates in comparison to other patient populations, such as surgical patients and the great 
importance of the early diagnosis and the early onset of a targeted antimicrobial therapy in 
order to achieve an acceptable posttransplant outcome [21-24]. Kim et al. reported also 
similar risk factors in their study about bacteriemia in living donor liver transplant 
recipients (LDLT) [25]. Several authors reported in their studies an increased infection risk 
in LDLT because of the small graft size, which might lead to an increased portal venous 
pressure with impaired bowel motility with consecutive bacterial translocation, which 
increases the risk for a bacterial infection [26,27]. Igekami et al reported in a large study with 
LDLT recipients that late enteral nutrition and great blood loss during operative procedure 
were significant and  independent risk factors for a bacterial sepsis in the posttransplant 
setting [28].  The early start of enteral nutrition could be effective in transplant patients, 
because of the stimulating effect in terms of bile flow, the enterohepatic circulation and 
portal blood flow, preventing an atrophia of the intestinal mucosa and a bacterial 
translocation [28]. Furthermore high MELD score and the co morbidity of recipients seem to 
have a significant effect on the onset of bacteriemia and septic complications after OLT.  
Bacteriemia accounts for up to 30% of all major infections after liver transplantation with an 
considerable mortality risk of 20% to 39% [21-28]. The main sources for bacteriemia and 
systemic infection, occurring within the first 3 months after OLT,  are infected vascular 
catheter sited, pneumonia and infections of the biliary tract in terms of cholangitis following 
a biliary disorder( stenosis, ITBL, presence of  biliodigestive anastomosis)  [29]. Several 
authors examining blood stream infections in the posttransplant setting in their studies have 
shown that gram negatives, particularly, Klebsiella and Pseudomonas, tend to be the 
predominant species [30]. Furthermore Karvellas et al reported in a large study that the 
predominant species was enterococcus. Significantly more patients in the infected group 
had a biliodigestve anastomosis [30]. 
As underlined before, several studies have examined the risk factors and the onset of post-
transplantation bacterial and fungal sepsis in patients undergoing OLT. Clinical signs of an 
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infection (dysregulation of temperature, tachycardia) are either absent or nonspecific [4,13 
31-44]. Various authors underlined the great importance of early initiation of a targeted 
antimicrobial therapy or the preemptive therapy in high-risk patients in order to achieve 
acceptable outcomes by preventing generalized sepsis, septic shock and multiorgan 
dysfunction.  
Especially bacterial sepsis has a significant impact on the survival of patients who 
undergo a transplant proceeding because of the surgical trauma and the need for 
immunosuppression [1-4]. 
Furthermore, commonly used biochemical markers, such as C-reactive protein (CRP) or 
leucocyte count, cannot be considered to be specific inflammation markers in the early 
postoperative setting in order to establish a definite diagnosis [42].  
2. Body 
2.1. Procalcitonin; background 
Calcitonin, a 32-amino-acid amidated hormone, is initially biosynthesized as a precursor, 
named preprocalcitonin [45] This protein is processed into several calcitonin precursors. In 
adults and children, infection and sepsis have been found to be associated with increased 
serum levels of calcitonin precursors [46-53]. These concentrations were shown to be 
positively correlated with a subsequent mortality rate [45]. Circulating calcitonin precursors, 
including procalcitonin, are raised in severe bacterial infections, but remain in low or 
normal ranges in viral infections and non-specific inflammatory diseases.(38,45,46).  
Procalcitonin (PCT) is a precursor protein of the hormone calcitonin with a molecular 
weight of approximately 13 kDa. PCT is induced in the plasma of patients with severe 
bacterial or fungal infections or sepsis [38,40-54]. Local bacterial infections, viral infections, 
autoimmune and allergic disorders do not induce PCT. At present, it is not clear whether 
PCT is predominantly influenced merely by inflammation induced by microbial infections, 
or also by the severity of multiple organ dysfunctions secondary to the systemic 
inflammatory response. 
Procalcitonin (PCT) is identified as a diagnostic marker for infectious or septic processes and 
correlates better with its severity as CRP [5, 44-57]. PCT is an acute phase protein, composed 
of 116 amino acids and is the precursor of calcitonin. In healthy individuals, PCT serum 
concentrations are very low (<0,5mg/dl). The half-life of PCT is approximately 26 to 30 hours 
[38-40]. Neuroendocrine cells of solid organs (lung, kidney, pancreas, adrenal gland, and 
liver) might be the source of PCT during an inflammatory procedure. A further role might 
play extrathyroid cells, such macrophages, monocytes and liver cells in the PCT production 
during sepsis [40, 41]. The main hypothesis as far as the PCT induction is concerned, 
presents that the stimulation for PCT elevation is a result of a systemic challenge of the 
organism with bacterial endotoxin and bacterial polysaccharides [39]. Overall the exact 
pathophysiology is still an open matter. [38,40].  
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2.2. PCT after liver surgery and in hepatic dysfunction 
Procalcitonin (PCT) is a well established marker indicating a complication such as 
inflammation or sepsis among surgical patients. PCT rises 24–48 hours before and correlates 
better with the severity of sepsis and infection than CRP. In uncomplicated liver surgery 
cases, PCT peaks at 24 hours after the Pringle maneuver (clamp of the hepatoduodenal 
ligament) with a half-life of 24–30 hours. It has been reported that the liver has a primary 
role as the source of PCT production during endotoxin shock [24] In cirrhotic patients with 
impaired hepatic synthetic function, PCT levels were not lower, displaying the same 
predictive power for infection as in patients without cirrhosis [44].     
2.3. PCT in trauma and surgery 
Meissner et al emphasizing the differences in the kinetics of the main inflammation markers 
(PCT, CRP) after trauma and surgery, reported in their study that unlike CRP, PCT values 
typically declined rapidly after trauma. The rapid decline of the initial induction of PCT 
after trauma or surgery compared with the long-lasting increase of CRP promises an earlier 
use of PCT as a marker of sepsis and infection than of CRP in the postoperative 
/posttraumatic phase. He also demonstrates that the CRP level in trauma patients is not a 
valid parameter to gather more information about the severity of systemic inflammation, 
complications, and prognosis of the patient. PCT and clinical score systems are superior to 
CRP for risk stratification of the patient. On the contrary, the diagnostic use of CRP after 
trauma is limited because of its slow kinetics [35, 37, 39, 54, 55]. Other studies emphasize the 
major role of early changes of PCT levels for predicting the final outcome of septic patients. 
Any decrease of serum PCT within the first 48 hours by 30% or its persistence at levels 
within the normal ranges was an indicator of favorable outcome. On the contrary, any 
increase of serum PCT after 48 hours or any minimal decrease is a sign for insufficient 
antimicrobial therapeutic strategy. This finding applied both for patients with sepsis and for 
patients with severe sepsis/shock. It was a factor related to final outcome independently 
from disease severity.  
2.4. PCT in OLT 
However, the prognostic value of procalcitonin in liver transplant recipients, undergoing 
immunsuppression and showing severe co morbidities remains to be determined. Initially 
high PCT levels do not necessarily indicate a poor prognosis as do continuous or 
secondarily rising levels or elevations in the later postoperative course [42, 43]. In the 
posttransplant setting, elevated PCT levels are observed in the first 2-3 days after OLT [1]. 
Initially high PCT levels, however, do not necessarily indicate a poor prognosis as do 
continuous or secondarily rising levels [32,42]. Cardiac arrest and infection, but not PCT 
level in the donor, are associated with high post- OLT PCT levels in the recipient [43]. In 
patients with impaired hepatic synthesis, PCT levels were not lower; displaying the same 
predictive relevance for infection as in septic patients without cirrhosis or impairment of the 
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liver function [44]. PCT has been shown to increase among OLT patients with infections, but 
it fails to predict an acute rejection episode.  Furthermore, PCT rises in all patients 
undergoing OLT owing to the perioperative distress.  
Coelho et al reported in a study with pediatric liver transplant recipients that it was possible 
to differentiate between bacterial infection and rejection by PCT measurement. In all 
patients with bacterial infection, an increase in PCT was to register. On the other hand 
patients suffering from acute graft rejection and these having an uneventful posttransplant 
course did not show an increase of PCT [56]. 
Furthermore an ATG (antithymocyte globulin)-based immunosuppressive therapy is a 
stimulus for synthesis and further elevation of PCT [53]. This fact presents the major 
limitation of PCT’s diagnostic power. Additionally the presence of viral infection did not 
stimulate a PCT elevation and cannot be diagnosed through this inflammation marker 
[32,37-60].  
Van den Broek et al [32] in a large study with 135 patients (LDLT and deceased donor 
recipients) examined the diagnostic and prognostic accuracy of PCT in cases of critical 
systemic infections in comparison to other traditional inflammation markes such as CRP 
and leucocyte count (LC). In this study peak PCT was found not to be an independent factor 
for occurrence of serious infections and septic episodes. On the other hand the authors 
underlined the importance of CRP, as it was found to be an independent risk factor for a 
critical systemic infection. Eyraud et al [43] investigated also the relevance of PCT in the 
posttransplant setting after OLT. The results of this study could not confirm them of 
previous studies [58,59] reporting that peak PCT could have its origin either from an 
infection of the recipient or from cardiac arrest of the donor. In this study the clinical 
characteristics of the donor are emphasized: the initial PCT of recipient has its origin from 
donor's cardiac arrest and it could not be predictive of graft dysfunction or postoperative 
complications after OLT. Furthermore graft preservation, graft flushing and type of 
reperfusion are factors, which have a significant influence on initial PCT values and this is 
one of the main bias as far as the sensitivity of PCT in the early posttransplant phase is 
concerned. Therefore Fazakas et al proposed standard procedures for graft harvesting, 
timing and technique of graft flushing in order to avoid the pathophysiological conditions, 
which lead to this bias [59]. 
The most significant value as far as the diagnostic power of PCT is concerned is the fact, that 
PCT levels increase far less than CRP levels, and the period of unspecific induction is much 
shorter [54].  
2.5. PCT in MODS 
In another large study with critically ill patients Meissner and colleagues indicate that PCT 
concentrations are associated with the severity of multiorgan dysfunction (MODS) during 
sepsis as assessed by the SOFA (sepsis-related organ failure assessment) score [39].  PCT has 
several advantages in severely ill patients compared with CRP. The most striking one, 
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demonstrated in his study, is the enormous range of PCT reactivity resulting in a marked 
increase in PCT plasma levels, especially during severe stages of MODS and systemic 
inflammation. On the other hand, PCT concentrations are quite low when only a moderate 
organ dysfunction or a weak systemic inflammatory response is present. In contrast, CRP 
levels are often found to be already increased to maximal concentrations in patients with 
low SOFA scores. Thus, CRP cannot provide information as to further increases in organ 
dysfunction and the inflammatory progress, respectively, since it is already increased to its 
maximum values during a less severe stage of disease. Further advantages of PCT are its 
more rapid kinetics; PCT reacts faster than CRP both during an increase or decrease of 
inflammation. Regarding the prognosis of the disease, the course of PCT after day 4 from the 
onset of systemic inflammation was able to distinguish survivors from non-survivors. In 
summary, PCT compared with CRP is characterized by its ability to be induced to very high 
serum concentrations also during advanced stages of MODS and severe systemic 
inflammation, respectively, whereas CRP is often already in the upper concentration range, 
even in patients with low severity scores, and exhibits no such further dynamics during the 
course of MODS and systemic inflammation. PCT more rapidly declines to the normal range 
during the recovery of the patient compared with CRP, and thus provides more information 
in patients with MODS and sepsis of various etiologies than CRP.  
Therefore the examination and the careful evaluation of postoperative PCT values are the 
most important stages for the early diagnosis of sepsis and infection after surgery.  
Various authors and we emphasize the fact that  the diagnostic accuracy of procalcitonin is 
completely dependent on use of a sensitive assay in an appropriate clinical setting. The 
clinical signs, physical examination and the clinical setting cannot be substituted by 
procalcitonin. They must be seen as complementary tools for early establishment of 
diagnosis. [38,42] 
2.6. PCT: Our observations during liver transplantation 
Aim of our research was to evaluate PCT as an early prognostic marker within 48 hours 
after OLT for subsequent postoperative complications and to assess the prognostic accuracy 
of PCT as marker for infectious and non infectious postoperative complications, septic 
episodes and as predict factor as far as the in hospital mortality is concerned. Our research 
included a retrospective study in a cohort liver transplant recipients underwent 32 liver 
transplantations [42] and a prospective part including patients underwent 75 OLT. 
Patients with irreversible end-stage liver disease that was life threatening and refractory to 
other forms of conventional medical or surgical therapy who had no contraindications for 
transplantation were regarded as eligible for OLT. The organs were allocated according to 
the Model of End Stage Disease (MELD) [61] 
For each recipient, the following were recorded: age, gender and PCT serum concentration 
before, 6 hours after reperfusion and then daily during the stay in the ICU after OLT.  
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Blood samples were obtained for routine testing (biochemical parameters), and for each 
patient, serum aliquots were used for PCT determination. The procalcitonin levels were 
measured by an immunoluminometric LUMItest PCT kit (Brahms; Diagnostica, Berlin, 
Germany) ; the normal range detected was from 0.1 to 0.5 ng/mL.  
Postoperative clinical course was prospectively analyzed from admission to discharge 
according to main clinical data: infectious/non infectious complications, septic episodes, graft 
disorders, acute rejection episodes, renal failure, multiorgan failure and need for re-
transplantation. Complications were graded according to the classification of Dindo et al [62]. 
2.6.1. Definitions for our protocol 
Graft dysfunction was defined as the occurrence of at least one of the following criteria: the 
need for retransplantation (primary non function, PNF), a rise in aminotransferases of above 
2,000 UI/L, impairment of factor V (<30%) with synchronous increase of bilirubin without a 
retrospective need for retransplantation, serum bilirubin greater than 10 mg/ml; PT of at 
least 17 sec; hepatic encephalopathy [63]. Mortality was defined as death from any cause 
occurring during the hospital stay. 
Pulmonary complication was defined as the need for mechanical ventilation. 
Acute renal failure was defined as plasma creatinemia of greater than 2mg/dl and urine 
output of less than 0.5 mL/hour. Renal complication was defined as the need for dialysis 
after OLT or greater than 100% of creatinine levels compared with preoperative values. 
Postoperative complication was defined as hepatic dysfunction, infection, or pulmonary or 
renal complication or other surgical complication such as bleeding, hepatic artery 
thrombosis (HAT), thrombosis of the portal or cava vein and biliary complication such as 
insufficiency, stenosis, ITBL(ischemic type biliary lesion). 
The definition of clinical infection was standardized with criteria proposed by the Centers 
for Disease Control and Prevention and included pulmonary, bloodstream, or intra-
abdominal infections accompanied by clinical symptoms proven by microbiological, 
radiological, or surgical findings and reacting to instituted therapy. 
Infection was diagnosed if clinical; biochemical or radiologic signs of infection were evident. 
Chest X-rays, ultrasound examinations were performed on daily basis during the ICU stay 
and computed tomography (CT) scans when a clinical infection was suspected, and on the 
basis of these examinations, prompt therapy was initiated. In cases where samples from the 
suspected site of infection were positive, a proven infection could be defined. 
Sepsis was defined by the presence of infection and SIRS (systemic inflammatory response 
syndrome). The criteria for SIRS were met if more than one of the following signs occurred: 
a body temperature greater than  38°C or less than 36°C, a heart rate greater than 100 beats 
per minute, hyperventilation as evidenced by a respiratory rate greater than 20 breaths per 
minute or a partial pressure of carbon dioxide in the arterial blood less than 32 mm Hg, and 
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an LC greater than 10.000 cells/μl or less than 4.000 cells/μl.5 Severe sepsis was defined as 
sepsis complicated by organ dysfunction [64]  
2.6.2. Immunsuppression protocol and antibiotic prophylaxis 
All patients were initially treated with tacrolimus, starting 36 hours after transplantation at 
0.1 mg/kg twice daily and 500 mg methylprednisolone in the anhepatic phase. All patients 
received basiliximab (Simulect, 20 mg) in the anhepatic phase followed by a second 
administration (20mg), 4 days after transplantation. Mycophenolate mofetil (500 mg twice 
daily, intravenous or per oral) was administered starting on the 5th postoperative day. Acute 
rejection was diagnosed based on the histopathological examination after liver biopsy 
according to BANFF criteria [65]. In patients with tacrolimus neurotoxicity and other 
Tacrolimus triggered side effects,  a conversion of the immunsuppressive regimen to 
Ciclosporin- based immunsuppression was performed. All recipients received broad-
spectrum antimicrobial prophylaxis, consisting of antibacterial, antiviral, and antimycotic 
agents: with piperacilline-tazobactam for 7 days aciclovir and anidulafungin/posaconazole. 
Selective digestive decontamination consisted of 200mg of oral amphotericin B 3 times daily 
until the 21st postoperative day. Furthermore, high-risk patients, recipients of a 
cytomegalovirus (CMV) – positive donor received preemptive antiviral treatment with 
ganciclovir/ valganciclovir adjusted to renal function over a 6-week course. The standard 
laboratory workup included hematologic and biochemical parameters. The CMV status 
(viral load, pp65 antigen) was examined twice a week. Cytomegalovirus (CMV) infection 
was defined by the appearance of CMV antigen polymerase chain reaction in the blood.  X-
Ray examinations of the chest and ultrasounds of the graft were performed daily. 
2.6.3. Liver transplantation 
The donor organ was always retrieved as part of a multiorgan donation. Either University of 
Wisconsin (UW)  or histidine-tryptophan-Ketoglutarate (HTK) solution was used for 
preservation. Liver transplantation was performed by using either the retrocaval resection 
technique or  the piggyback technique. We performed either simultaneous portoarterial 
reperfusion or a portal reperfusion of the graft in a ratio 1:1. All patients were indicated for 
OLT because of end stage liver disease. Indications for OLT were: 1. acute liver failure, 2. 
hepatocellular carcinoma inside the Milan criteria, 3. hepatitis C induced liver cirrhosis, 4. 
hepatitis B induced liver cirrhosis , 5. nutritive toxic liver cirrhosis , 6. hemochromatosis , 7. 
autoimmunhepatitis . The median MELD score was 33 and 33 OLT were performed after 
acceptance of a request for high urgency (HU) liver transplantation 
2.6.4. Statistics and results 
Linear regression was used in univariate analysis to identify predictors of elevated PCT 
concentrations. Multivariate analysis was carried out using a logistic regression model. All 
of the tests performed were two-sided. Significant predictors in univariate analysis were 
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included in a multivariate linear regression model, with a stepwise variable selection 
method. Potential associations between infectious complications or overall complications 
and surgical, clinical or biological parameters were tested with univariate procedures, using 
students’ paired t-test for continuous variables and Pearson’s chi-square test for categorical 
variables. P-values of less than 0.05 were considered to be statistically significant.  
Statistical analysis was done with SPSS (SPSS v19.0, Chicago, IL, USA).  
In the retrospective part of our research 32 adult patients with end-stage liver disease 
underwent OLT.  
In 29 patients the peak-PCT occurred within 48 hours after OLT. A rapidly rising PCT was 
observed in 2 patients associated with subsequent fatal outcomes. Among the 10 patients 
with peak-PCT values less than 5 ng/mL, 9 displayed uneventful postoperative courses. PCT 
values more than 5 ng/mL were observed among 22 patients with 23 OLT, including 12 with 
13 OLT who suffered more than 1 complications. The odds ratio (OR) for a complicated 
course in the presence of an initial PCT  more than 5 ng/mL was calculated to be 11.7 (95% 
Confidence interval, 11.3–12.1; P  <.025) with risk ratio of 5.65. The risk of renal failure 
requiring hemofiltration was independent of a PCT more than 5 ng/mL (OR 8.25; P < 0 .04). 
Total bilirubin was significantly higher among patients with an initial PCT  more than 5 
ng/mL until day 7, compared with patients with a PCT less than 5 ng/mL. GOT was 
significantly higher on days 2 and 3 in these groups, but peak values for GOT and total 
bilirubin correlated significantly on univariate analysis . CRP did not show any significant 
difference between the complication and non-complication groups. The 
immunosuppression regimen was not significantly different regarding the occurrence of a 
complication or the occurrence of a peak-PCT of 5 ng/mL. 
In the prospective part of our research patients with end-stage liver disease patients 
underwent 75 OLT. In this part we examined the clinical significance of the occurrence of a 
2nd PCT peak, after the initial PCT peak, which occurs in the immediate post transplant 
setting. 
In 65 patients the initial peak-PCT occurred within 72 hours after OLT. Patients with initial 
PCT values >5 ng/mL had a significantly higher risk to suffer more than 1 complications 
(infectious, non-infectious).   
Overall 42 complications (infectious, non-infectious) were registered and there was a 
significant relevance with the occurrence of a 2nd PCT peak to register. In patients with a 
graft dysfunction, including acute rejection episodes, there was a significant PCT elevation 
with the occurrence of a 2nd peak. However in some patients there was a coincidence of an 
infectious focus to register. This fact was without statistical significance  Among  patients 
with a PNF and the need of re-transplantation, there was a significant elevation of PCT with 
the occurrence of a 2nd peak. On the contrary in patients with a HAT a 2nd PCT peak could 
not be registered.  
Patients with biliary complications did not show an elevation of PCT or a 2nd peak. Patients 
which displayed an acute renal failure after OLT with the intermittent need for CVVH 
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(continuous veno-venous hemofiltration), but there was no relevance between this 
complication and the PCT course. Furthermore the risk of renal failure requiring 
hemofiltration was independent of an initial PCT > 5 ng/mL 
Furthermore we register that there was no relevance between the 1st peak-PCT and the 
further postoperative course or the occurrence of complications (infectious or non-
infectious, p=0.442).  
Patients, in which a 2nd PCT peak was occurred, had a significantly higher risk for a 
complicated course, for a complicated sepsis course with multiorgan dysfunction, for a non 
infectious complication (p<0.0001) and for in-hospital mortality (p<0.0001). 
2.6.5. Interpretation of our findings 
However, the peak value of PCT, usually occurring 2nd or 3rd postoperative day, was not 
an independent factor for a fatal outcome according to the present series. An initially high 
PCT has been described to not indicate a poor prognosis when followed by an adequate 
decline. A rapidly rising PCT without a decline after the 3rd postoperative day is associated 
with a fatal outcome correlating with a bacterial or fungal infection. In contrast to earlier 
studies where an elevation of PCT was seen only in infectious complications, we also 
observed a greater number of noninfectious complications. The high PCT did not predict the 
type or severity of the complication in general practice, but among transplant patients a 
further elevation was seen only in bacterial infections and not in rejection episodes or local 
inflammation. We observed a rise of PCT in respiratory failure and sepsis, but not in 
occurrence of ascites, pleural effusion, acute rejection episodes, or bleeding, as reported by 
other authors. 
An initially high PCT has been described not  to indicate a poor prognosis. Furthermore it is 
generally accepted that ischemic times as well as reperfusion produce a proinflammatory 
response of impaired liver function. Owing to tissue damage which predisposes to 
generalized infection and postoperative sepsis. In addition, elevated PCT values did not 
suggest a graft rejection process.  
Furthermore our results show that OLT recipients with infectious and some non infectious 
complications had significantly higher values of PCT, in the majority of cases with a 2nd peak 
value after the initial PCT peak, in comparison to recipients with an uncomplicated post 
transplant course. The 1st peak PCT was not an independent risk factor in LTx recipients, 
while the occurrence of a 2nd peak was a significant independent factor for protracted septic 
course, for any complication overall (infectious or non infectious) and for post transplant 
mortality. The fact that the 1st PCT peak does not play a diagnostic and prognostic role 
underlined also Eyraud et al [43]. In this study was stated that PCT level in the donor and 
early PCT peak in the recipient have not a predictive value as far as post-OLT hepatic 
dysfunction or other complications are concerned. Cardiac arrest and infection in the donor 
seem to be associated with high post- OLT PCT levels in the recipient. As underlined before 
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a major limitation as far as the diagnostic accuracy of PCT is concerned stated Zazula et al, 
who reported the ATG-stimulated elevation of PCT [53]. This aspect was not a limitation of 
our research, as we prefer ATG-free immunsuppressive regimens.  
The occurrence of a 2nd PCT peak and of an eventful post transplant setting was significant 
in patients with a severe sepsis, bacterial or fungal infection and graft dysfunction overall 
(PNF and AR). In AR alone there was not a prognostic value of PCT to register. What this 
matter is concerned our results confirmed our first reports, as far the relevance between the 
1st PCT peak and the AR is concerned [42].  
In contrast to earlier studies where an elevation of PCT was seen only in infectious 
complications we also observed a greater number of non infectious complications when the 
PCT was elevated or showed a 2nd peak.  
Our research included an acceptable cohort of deceased donor OLT recipients and showed 
that PCT was an independent risk factor for infectious and some non-infectious 
complications and that the occurrence of a 2nd peak was an independent factor for a 
complicated postoperative outcome and for mortality. Furthermore we registered a high 
prognostic value, due to its occurrence before clinical onset of the complications and clinical 
impairment of the patients.   
Various studies have demonstrated that PCT is a useful diagnostic marker for bacterial and 
fungal infections and sepsis in different patient groups with superior diagnostic accuracy in 
comparison with CRP [34, 44, 55, 57]. Furthermore PCT was described in some small cohort 
studies as an accurate marker for any complication in the post transplant setting [57,58,60], 
which could not be fully confirmed by other study groups and by the present series 
[32,42,43].  
However this research reports the significance of the role of PCT as independent factor as 
far as its course and the 2nd peak are concerned. We have to admit that PCT must not be 
regarded to be the only reliable diagnostic parameter. Postoperative complications after 
liver transplantation may result from multifactorial processes [66,67], which cannot be 
monitored by only 1 marker.  
3. Conclusions 
OLT is a complex procedure with a great and very important physiological and 
pathophysiological background and many parameters and biochemical pathways, which 
have to be taken into consideration after the operating procedure. The most common 
complication after OLT is the occurrence of systemic infection and sepsis. The great 
operative stress, the immunsupression and other parameters, such as the reperfusion injury 
of the graft lead to a higher risk for occurrence of a septic complication with high morbidity 
and mortality rates. Therefore the sufficient monitoring of this patient population, the early 
diagnosis and the immediate treatment of an  infectious complication are of great 
importance. During the last years several studies and research have been performed in 
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order to find the "ideal infectious marker" with high sensitivity and specificity for the early 
establishment of an infectious complication. Common inflammation markers such as LC and 
CRP cannot be considered as sufficient markers in order to diagnose quickly an infectious 
complication in the posttransplant setting. IL-6 has advantages and disadvantages and is not 
enough investigated, especially in the clinical area and the endothelial adhesion molecules 
(ICAM-1, VCAM-1, ECAM-1) have not been proofed. PCT is nowadays a well established 
sepsis marker. However PCT must not be regarded to be the only reliable diagnostic 
parameter. Postoperative complications after liver transplantation may result from 
multifactorial processes, which cannot be monitored by only 1 marker. However, the values 
and especially the trend after the peak value of PCT seem to be important diagnostic tools to 
detect serious infectious complications. Based on our results we believe that the value of 
PCT and of the occurrence of a 2nd peak seem to be important diagnostic tools for the early 
detection of serious infectious complications. Of great importance is to examine the 
correlation between PCT course, clinical course and CRP. This must be regarded as the basis 
of the post transplant management of a liver recipient.  Furthermore our clinical research 
revealed that patients experienced great benefit from prophylactic and preemptive 
antibacterial, antifungal, and antiviral therapy. 
The relevance and the importance of PCT and its course during the post transplant setting 
should be further examined in randomized controlled studies on multicenter basis. 
Furthermore we believe that inflammation markers such as IL-6 should be further examined 
e.g. in combination with PCT, because IL-6 is an extremely sensitive marker and could fill 
the "diagnostic gap" of PCT as far as viral infections are concerned. Endothelial adhesion 
molecules, which have the best sensitivity among the inflammation markers, are until today 
not examined and in our opinion have still a role to play. 
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